Business Asset Buyers

Background: Bank Danamon was established on July 16, 1956, as PT Bank Kopra Indonesia. In 1976, the bank's name was changed to PT Bank Danamon Indonesia. It began focusing on foreign exchange transactions in 1976 and listed its shares on the Jakarta Stock Exchange in 1989. In December 2017, Japan's Mitsubishi UFJ Financial Group (MUFG) bought a 19.9% stake in Danamon from Temasek Holdings for IDR 15.875 trillion ($1.17 billion). The price indicated Danamon was valued at about $6 billion. In July 2018, Indonesia's Financial Services Authority (OJK) approved MUFG’s plan to purchase a further 20.1% stake from Asia Financial. [3] On April 2019, MUFG announced the merger of Danamon and Bank Nusantara Parahyangan (BNP). The merger resulted in MUFG becoming the majority shareholders with a 94.1% stake in Bank Danamon.

Background: Manager of a Media company with 18 years of work experience. Willing to invest in a business.

Background: We are a dental group with alliance clinics in Malaysia & Singapore, explore to invest in marketing & branding company across Asia & Australasia.

Background: We are a dental group with alliance clinics in Malaysia & Singapore, explore to invest in marketing & branding company across Asia & Australasia.

Background: An international group with a French identity having strong experience in restaurant management. Within our development perspective, we want to invest in restaurants to import French know-how to the Indian market.

Background: I represent a private investment and operating group based in the Philippines with a strong background in consumer brands, e-commerce, and cross-border business development. We actively build and scale multi-brand platforms across online and offline channels, with hands-on experience in brand strategy, operations, supply chain, and regional market expansion. Our approach goes beyond capital; we focus on professionalising systems, strengthening management teams, improving unit economics, and unlocking growth through digital commerce and new market entry. We typically engage as a long-term partner, working closely with founders and local teams to improve profitability, scalability, and enterprise value.

Background: We are a global private investment holding capital venture company specialising in governmental gateway infrastructure redevelopment focusing on social-economic development. We are involved in rejuvenation governmental CIQS marina and port-related downstream projects in acquiring, managing, IPO/RTO portfolio preparation, disposing of companies in ASEAN. We have been involved in fly-cruise, security infrastructure project planning since 2011 to expand our business expertise and to seek strategic downstream businesses to support our private investment KPI in compliance with international standards.

Background: - I am a C-suite executive with over 20 years of leadership experience in multinational corporations, currently overseeing R&D investments across the APAC region. I hold a PhD in Chemical-Bioengineering and manage significant annual R&D budgets. I have deep expertise in scaling technology-driven businesses, particularly in medical devices, deep-tech, and climate-tech sectors. - I bring extensive experience in cross-border operations and can support portfolio companies with strategic direction, innovation, commercialisation, and international expansion across key Asian markets, while also providing cross-cultural leadership at the board or CEO level. I am looking for good investment opportunities, and I will be investing personally.

Background: I have experience in an electrical & electronics manufacturing firm.

Background: We own a chain of pharmacies in the UK. We aim to leverage industry expertise to grow our business and ensure optimal health solutions for communities.

Background: Who We Are: We are a group of strategic investors with deep expertise in the Pharma and Healthcare sectors. Our syndicate includes UHNIs and owners of established listed companies, providing us with a unique advantage in scaling businesses to IPO readiness. Our Value Proposition: Strategic Investment: We are not just financial backers; we bring extensive industry knowledge and connections to help companies grow strategically. Growth Focus: Our goal is to help companies achieve a minimum revenue of ₹200 Crore within three years of our investment. Niche Market Focus: We specifically target companies in niche sectors of Pharma and Healthcare, avoiding commodity products and trading businesses. Investment Criteria: We seek to invest in companies that meet the following criteria: Revenue: Current sales of at least ₹10 Crore. Hero Brand: At least one established product that drives significant revenue. Gross Margin: Minimum of 45%, with potential to scale to 55%. EBITDA: Currently around 10%, with a target to scale to 25%. Profitability: No loss situation currently, with a goal to achieve a net margin of 15%. Investment Range: We can invest between ₹1 Crore to ₹25 Crore as a group, depending on the opportunity and alignment with our strategic goals. Next Steps. If you are a company in the Pharma or Healthcare sector that aligns with our investment criteria, we would love to connect and explore potential collaboration.

Background: I am the CEO & president of a BPO company.

Background: Plant of medical healing pharma water.

Background: I worked as a store in-charge in the food and beverage industry. I focus on ensuring products meet quality standards.

Background: Director of an IT & BPO company based out of Cuttack.